An investigational cannabinoid (CBD) derived therapy is advancing to a Phase II trial to investigate its effects on ...

Neurotech International Limited announced the publication of its Phase I/II autism spectrum disorder (ASD) clinical trial results in the journal Advances in Complimentary and Alternative Medicine.

Prevalence was 3.4 times higher among boys than girls and was lower among White children versus those of other races/ethnicities ...